1-8 of 8
Kevin H. Mayo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-3: Evidence that dibenzofuran based anti-angiogenic, anti-tumor peptidomimetics target galectin-1

Ruud P.M. Dings, Michelle C. Miller, Nigam Kumar, Kevin H. Mayo
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): LB-3.
https://doi.org/10.1158/1538-7445.AM2012-LB-3
Published: 15 April 2012
View article titled, Abstract LB-3: Evidence that dibenzofuran based anti-angiogenic, anti-tumor peptidomimetics target galectin-1
Journal Articles

Abstract 3293: Activity and safety of an antiangiogenic peptide in spontaneous head and neck squamous cell carcinoma in cats

Elizabeth A. McNiel, Nicole J. Madrill, Jose O. Esteves-Villanueva, Pedro A. Dominguez, Ruud Dings, Kevin H. Mayo, Robert J. Griffin
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3293.
https://doi.org/10.1158/1538-7445.AM2011-3293
Published: 15 April 2011
View article titled, Abstract 3293: Activity and safety of an antiangiogenic peptide in spontaneous head and neck squamous cell carcinoma in cats
Journal Articles

Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications

Debby M.E.I. Hellebrekers, Karolien Castermans, Emmanuelle Viré, Ruud P.M. Dings, Nicole T.H. Hoebers, Kevin H. Mayo, Mirjam G.A. oude Egbrink, Grietje Molema, François Fuks, Manon van Engeland, Arjan W. Griffioen
Journal: Cancer Research
Cancer Res (2006) 66 (22): 10770–10777.
https://doi.org/10.1158/0008-5472.CAN-06-1609
Published: 15 November 2006
View article titled, Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications
Open the PDF for Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications in another window
Includes: Supplementary data
Journal Articles

Angiostatic compounds stimulate tumor immunity.

Karolien Castermans, Ruud P. Dings, Loes I. Van Eijk, Mirjam G. Oude Egbrink, Kevin H. Mayo, Arjan W. Griffioen
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1341.
Published: 15 April 2006
View article titled, Angiostatic compounds stimulate tumor immunity.
Journal Articles

Development of anti-angiogenic, anti-tumor peptidomimetics of anginex

Ruud P M Dings, Hanke Heun, Tom R. Hoye, Arjan W. Griffioen, Kevin H. Mayo
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 225.
Published: 15 April 2006
View article titled, Development of anti-angiogenic, anti-tumor peptidomimetics of anginex
Journal Articles

Non-peptide topomimetic of anginex as a potent anti-angiogenic, anti-tumor agent

Ruud P. M. Dings, Xuemei Chen, Victor L. Thijssen, Loes I. Van Eijk, Robert J. Griffin, Tom R. Hoye, Arjan W. Griffioen, Kevin H. Mayo
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1372.
Published: 01 May 2005
View article titled, Non-peptide topomimetic of anginex as a potent anti-angiogenic, anti-tumor agent
Journal Articles

Enhanced in vivo antitumor activity for the combination of irofulven and the antiangiogenic compounds, anginex or KM0118

Ruud P. M. Dings, Emily S. Van Laar, Stephen J. Waters, Jeremy G. Webber, John R. MacDonald, Kevin H. Mayo
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1177–1178.
Published: 01 May 2005
View article titled, Enhanced <em>in vivo</em> antitumor activity for the combination of irofulven and the antiangiogenic compounds, anginex or KM0118
Journal Articles

The Designed Angiostatic Peptide Anginex Synergistically Improves Chemotherapy and Antiangiogenesis Therapy with Angiostatin

Ruud P. M. Dings, Yumi Yokoyama, Sundaram Ramakrishnan, Arjan W. Griffioen, Kevin H. Mayo
Journal: Cancer Research
Cancer Res (2003) 63 (2): 382–385.
Published: 15 January 2003
View article titled, The Designed Angiostatic Peptide Anginex Synergistically Improves Chemotherapy and Antiangiogenesis Therapy with Angiostatin
Open the PDF for The Designed Angiostatic Peptide Anginex Synergistically Improves Chemotherapy and Antiangiogenesis Therapy with Angiostatin in another window